Section Arrow
AVR.NASDAQ
- Anteris Technologies Global Corp
Quotes are at least 15-min delayed:2026/03/09 15:38 EDT
Regular Hours
Last
 5.98
-0.23 (-3.70%)
Day High 
6.19 
Prev. Close
6.21 
1-M High
6.9494 
Volume 
958.35K 
Bid
5.97
Ask
5.99
Day Low
5.8081 
Open
6.05 
1-M Low
5.3 
Market Cap 
601.44M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 6.34 
20-SMA 6.01 
50-SMA 5.66 
52-W High 7.9 
52-W Low 2.34 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.55/--
Enterprise Value
602.08M
Balance Sheet
Book Value Per Share
-0.00
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
2.70M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ABTAbbott Laboratories112.7+3.14+2.87%29.21PE
MDTMedtronic plc91.41+0.51+0.56%25.39PE
BSXBoston Scientific Corp72.27+0.92+1.29%36.78PE
BFLYButterfly Network3.815+0.165+4.52%-- 
PACBPacific Biosciences of California1.375-0.005-0.36%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THVis a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.